Register now:
Our 17th Annual Scientific meeting
'Cardiorenal medicine – new targets, treatments and technologies'
will be held on Friday 7th October 2022

King’s Fund, 11-13 Cavendish Square,
London W1G 0AN



We are delighted that we are able to return to a face-to-face meeting in London this year.

The meeting will promote and share academic interest across the cardiorenal spectrum of disease taking in new targets, treatments and technologies in diabetes, heart failure, kidney transplantation, and chronic kidney disease.
Places for healthcare professionals are limited and will go fast!
Scroll down the page to see feedback from past delegates.


Pre-ASM satellite symposium webinar
Treatment advances in cardiorenal disease
Thursday 6th October 2022 at either 12.30–13.30 or 18.00–19.00 BST (GMT + 1).

As part of our activities for our 17th annual scientific meeting (ASM), we are providing this pre-recorded webinar, without charge, to healthcare professionals, particularly those who are unable to attend our Friday 7th October, face-to-face meeting, although we do hope you will be able to attend both.


Catch up with our webinars on demand

We now have a wide range of webinars you can watch on demand. These cover topics from heart failure in pandemic times, intravenous iron in cardiovascular and cardiorenal patients, RAAS inhibition and hyperkalaemia, key cardiorenal care in the COVID-19 pandemic, to improving clinical outcomes for patients with cardiorenal disease


The Cardiorenal Forum (CRF) is an independent group formed in 2006. The key objective of the group is to highlight the important clinical overlap that exists between patients presenting with a primary cardiovascular or renal problem. Our annual scientific meeting is our main event to bring together all involved in the management of such patients to share ideas and learn more about how to deliver high quality care. We also hold practical digital activities to focus on challenging aspects of managing cardiorenal patients


Cardiorenal Forum

98%

of delegates said the 2019 meeting was clinically excellent or good

98%

of delegates found the 2019 programme to be good to excellent

100%

of delegates said the 2019 meeting organisation was good to excellent